MRI Research Today is a free monthly online journal that collates and summarizes the latest research about MRI, including details on magnetic resonance imaging, neuroimaging, brain tumors.

Volume 4 (2008), Issue 1 (January)

1. Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration.
   Am J Alzheimers Dis Other Demen, 22(6): 474-88. [Abstract] [Full-text]
2. Longitudinal CSF isoprostane and MRI atrophy in the progression to AD.
   J Neurol, 254(12): 1666-75. [Abstract] [Full-text]
3. Detection of unstable carotid artery stenosis using MRI.
   J Neurol, 254(12): 1714-22. [Abstract] [Full-text]
4. Computer-assisted calculation of myocardial infarct size shortens the evaluation time of contrast-enhanced cardiac MRI.
   Clin Physiol Funct Imaging, 28(1): 1-7. [Abstract] [Full-text]
5. Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma.
   J Neurooncol, 86(3): 313-9. [Abstract] [Full-text]
6. Model gradient coil employing active acoustic control for MRI.
   MAGMA, 20(5): 223-31. [Abstract] [Full-text]
7. Functional MRI at 3T using intermolecular double-quantum coherence (iDQC) with spin-echo (SE) acquisitions.
   MAGMA, 20(5): 255-64. [Abstract] [Full-text]
8. Acute patellofemoral pain: aggravating activities, clinical examination, MRI and ultrasound findings.
   Br J Sports Med, 42(1): 64-7; discussion 67. [Abstract] [Full-text]
9. STIR MRI to direct muscle biopsy in suspected idiopathic inflammatory myopathy.
   J Clin Rheumatol, 13(6): 341-5. [Abstract] [Full-text]
10. Intra- and inter-observer reliability of MRI examination of intervertebral disc abnormalities in patients with cervical myelopathy.
    Eur J Radiol, 65(1): 91-8. [Abstract] [Full-text]
11. In vitro evaluation of alternative oral contrast agents for MRI of the gastrointestinal tract.
    Eur J Radiol, 65(1): 133-9. [Abstract] [Full-text]
12. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
    Eur J Radiol, 65(1): 154-62. [Abstract] [Full-text]
13. MRI evidence of white matter damage in a mouse model of Nijmegen breakage syndrome.
    Exp Neurol, 209(1): 181-91. [Abstract] [Full-text]
14. MRI findings in an adolescent with type I citrullinaemia.
    Pediatr Radiol, 38(2): 237-240. [Abstract] [Full-text]
15. Cardiac MRI of ischemic heart disease at 3T: Potential and challenges.
    Eur J Radiol, 65(1): 15-28. [Abstract] [Full-text]
16. Clinical advantages of 3.0T MRI over 1.5T.
    Eur J Radiol, 65(1): 2-14. [Abstract] [Full-text]
17. Artifacts in 3-T MRI: Physical background and reduction strategies.
    Eur J Radiol, 65(1): 29-35. [Abstract] [Full-text]
18. Cardiac cine MRI: Comparison of 1.5T, non-enhanced 3.0T and blood pool enhanced 3.0T imaging.
    Eur J Radiol, 65(1): 80-5. [Abstract] [Full-text]
19. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3T compared to FDG-PET-CT.
    Eur J Radiol, 65(1): 47-58. [Abstract] [Full-text]
20. Pharmacological MRI in awake rats predicts selective binding of alpha4beta2 nicotinic receptors.
    Synapse, 62(3): 159-68. [Abstract] [Full-text]
21. Addison's disease due to adrenal tuberculosis: MRI features.
    Abdom Imaging. [Abstract] [Full-text]
22. In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model.
    Neurobiol Aging. [Abstract] [Full-text]
23. Gadolinium-containing MRI contrast agents: important variations on a theme for NSF.
    J Am Coll Radiol, 5(1): 29-35. [Abstract] [Full-text]
24. Alterations of striatal glutamate transmission in rotenone-treated mice: MRI/MRS in vivo studies.
    Exp Neurol, 209(1): 224-33. [Abstract] [Full-text]
25. PROPELLER MRI visualizes detailed pathology of hippocampal sclerosis.
    Epilepsia, 49(1): 33-9. [Abstract] [Full-text]
26. Infarction of uterine fibroids after embolization: relationship between postprocedural enhanced MRI findings and long-term clinical outcomes.
    Cardiovasc Intervent Radiol, 31(1): 66-72. [Abstract] [Full-text]
27. Noncovalent functionalization of carbon nanotubes with amphiphilic gd3+ chelates: toward powerful t1 and t2 MRI contrast agents.
    Nano Lett, 8(1): 232-6. [Abstract] [Full-text]
28. Detecting faces in pure noise images: a functional MRI study on top-down perception.
    Neuroreport, 19(2): 229-33. [Abstract] [Full-text]
29. MRI in ocular drug delivery.
    NMR Biomed. [Abstract] [Full-text]
30. Digital nerve somatosensory evoked potentials and MRI. Correlation analysis in patients with symptomatic cervical spine disorders.
    Acta Neurol Scand, 117(2): 122-7. [Abstract] [Full-text]
31. MRI of the Perihemorrhagic Zone in a Rat ICH Model: Effect of Hematoma Evacuation.
    Neurocrit Care. [Abstract] [Full-text]
32. Magnetic resonance imaging (MRI) in the clearance of the cervical spine in blunt trauma: a meta-analysis.
    J Trauma, 64(1): 179-89. [Abstract] [Full-text]
33. Characterisation of carotid atheroma in symptomatic and asymptomatic patients using high-resolution MRI.
    J Neurol Neurosurg Psychiatry. [Abstract] [Full-text]
34. Effect of bezafibrate therapy on atherosclerotic aortic plaques detected by MRI in dyslipidemic patients with hypertriglyceridemia.
    Atherosclerosis, 196(1): 425-33. [Abstract] [Full-text]
35. The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston Leeds Osteoarthritis Knee Score).
    Ann Rheum Dis, 67(2): 206-11. [Abstract] [Full-text]
36. Dynamic contrast enhanced MRI of bone marrow oedema in rheumatoid arthritis.
    Ann Rheum Dis, 67(2): 270-2. [Abstract] [Full-text]
37. Influence of PDE5 inhibitor on MRI measurement of clitoral volume response in women with FSAD: a feasibility study of a potential technique for evaluating drug response.
    Int J Impot Res, 20(1): 105-10. [Abstract] [Full-text]
38. Micelles based on biodegradable poly(L-glutamic acid)-b-polylactide with paramagnetic gd ions chelated to the shell layer as a potential nanoscale MRI-visible delivery system.
    Biomacromolecules, 9(1): 36-42. [Abstract] [Full-text]
39. Conventional and diffusion-weighted MRI findings of methotrexate related sub-acute neurotoxicity.
    J Neurol Sci. [Abstract] [Full-text]
40. Detection of osseous metastases of the spine: Comparison of high resolution multi-detector-CT with MRI.
    Eur J Radiol. [Abstract] [Full-text]
41. MRI-Guided 3D Optimization Significantly Improves DVH Parameters of Pulsed-Dose-Rate Brachytherapy in Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. [Abstract] [Full-text]
42. A negative correlation between human carotid atherosclerotic plaque progression and plaque wall stress: In vivo MRI-based 2D/3D FSI models.
    J Biomech. [Abstract] [Full-text]
43. MRI assessment followed by successful mechanical recanalization of a complete tandem (internal carotid/middle cerebral artery) occlusion and reversal of a 10-hour fixed deficit.
    J Neuroimaging, 18(1): 93-5. [Abstract] [Full-text]
44. Diagnosis of Lacunar Infarcts within 6 Hours of Onset by Clinical and CT Criteria Versus MRI.
    J Neuroimaging, 18(1): 66-72. [Abstract] [Full-text]
45. Cerebral Changes in SLE With or Without Antiphospholipid Syndrome. A Case-Control MRI Study.
    J Neuroimaging, 18(1): 62-5. [Abstract] [Full-text]
46. Assessment of the cerebral vasomotor reactivity in internal carotid artery occlusion using a transcranial Doppler sonography and functional MRI.
    J Neuroimaging, 18(1): 38-45. [Abstract] [Full-text]
47. Identification of the Sensorimotor Cortex with Functional MRI: Frequency and Actual Contribution in a Neurosurgical Context.
    J Neuroimaging, 18(1): 28-33. [Abstract] [Full-text]
48. Enhanced sensitivity with fast three-dimensional blood-oxygen-level-dependent functional MRI: comparison of SENSE-PRESTO and 2D-EPI at 3 T.
    NMR Biomed. [Abstract] [Full-text]
49. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair.
    Heart, 94(2): 211-6. [Abstract] [Full-text]
50. Assessment of functional development in normal infant brain using arterial spin labeled perfusion MRI.
    Neuroimage, 39(3): 973-8. [Abstract] [Full-text]
51. How to trace stem cells for MRI evaluation?
    J Neurol Sci, 265(1): 122-6. [Abstract] [Full-text]
52. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
    Neurology, 70(3): 191-9. [Abstract] [Full-text]
53. Intramedullary tumours in patients with neurofibromatosis type 2: MRI features associated with a favourable prognosis.
    Clin Radiol, 63(2): 193-200. [Abstract] [Full-text]
54. Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis.
    Clin Radiol, 63(2): 153-9. [Abstract] [Full-text]
55. Heroin-induced leukoencephalopathy: characterization using MRI, diffusion-weighted imaging, and MR spectroscopy.
    Clin Radiol, 63(2): 146-52. [Abstract] [Full-text]
56. Hybrid two-dimensional navigator correction: a new technique to suppress respiratory-induced physiological noise in multi-shot echo-planar functional MRI.
    Neuroimage, 39(3): 1142-50. [Abstract] [Full-text]
57. Hypervascular hepatocellular carcinoma: Combined dynamic MDCT and SPIO-enhanced MRI versus combined CTHA and CTAP.
    Hepatol Res, 38(2): 147-58. [Abstract] [Full-text]
58. The use of functional MRI to evaluate cervical flexor activity during different cervical flexion exercises.
    J Appl Physiol, 104(1): 230-5. [Abstract] [Full-text]
59. Paramagnetic relaxation-based 19f MRI probe to detect protease activity.
    J Am Chem Soc, 130(3): 794-5. [Abstract] [Full-text]
60. Comparison of a tartaric Acid derived polymeric MRI contrast agent to a small molecule model chelate.
    Bioconjug Chem, 19(1): 24-7. [Abstract] [Full-text]
61. Novel Augmentation Therapy with Cilostazol for the Geriatric Major Depressive Disorder Patient with Deep White Matter Hyperintensities on T2-Weighted Brain MRI: A Case Report.
    Pharmacopsychiatry, 41(1): 37-9. [Abstract] [Full-text]
62. The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast.
    Eur J Surg Oncol, 34(2): 135-42. [Abstract] [Full-text]
63. Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI.
    Br J Pharmacol, 153(2): 367-79. [Abstract] [Full-text]
64. An MRI-compatible foot-loading device for assessment of internal tissue deformation.
    J Biomech, 41(2): 470-474. [Abstract] [Full-text]
65. In vivo lung morphometry with hyperpolarized 3He diffusion MRI: theoretical background.
    J Magn Reson, 190(2): 200-10. [Abstract] [Full-text]
66. MRI/linac integration.
    Radiother Oncol, 86(1): 25-9. [Abstract] [Full-text]
67. Optimum pulse flip angles for multi-scan acquisition of hyperpolarized NMR and MRI.
    J Magn Reson, 190(2): 183-8. [Abstract] [Full-text]
68. MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum.
    Acad Radiol, 15(2): 153-64. [Abstract] [Full-text]
69. The acutely ACL injured knee assessed by MRI: are large volume traumatic bone marrow lesions a sign of severe compression injury?
    Osteoarthritis Cartilage. [Abstract] [Full-text]
70. Novel MRI techniques in the assessment of dementia.
    Eur J Nucl Med Mol Imaging. [Abstract] [Full-text]
71. In vivo imaging of axonal transport using MRI: aging and Alzheimer's disease.
    Eur J Nucl Med Mol Imaging. [Abstract] [Full-text]
72. Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study.
    Int J Cardiovasc Imaging. [Abstract] [Full-text]
73. Transurethral microwave thermotherapy of the prostate - Evaluation with MRI and analysis of parameters relevant to outcome.
    Scand J Urol Nephrol, 42(1): 53-8. [Abstract] [Full-text]
74. Perineural Spread of Melanoma Demonstrated by F-18 FDG PET With MRI and Pathologic Correlation.
    Clin Nucl Med, 33(2): 106-108. [Abstract] [Full-text]
75. Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis.
    Mult Scler. [Abstract] [Full-text]
76. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing remitting multiple sclerosis.
    Mult Scler. [Abstract] [Full-text]
77. Atlas-based multichannel monitoring of functional MRI signals in real-time: automated approach.
    Hum Brain Mapp, 29(2): 157-66. [Abstract] [Full-text]
78. 3-T MRI in the preoperative evaluation of depth of myometrial infiltration in endometrial cancer.
    AJR Am J Roentgenol, 190(2): 489-95. [Abstract] [Full-text]
79. MRI features of posterior capitellar impaction injuries.
    AJR Am J Roentgenol, 190(2): 435-41. [Abstract] [Full-text]
80. Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography.
    AJR Am J Roentgenol, 190(2): 396-405. [Abstract] [Full-text]
81. Dynamic oxygen-enhanced MRI versus quantitative CT: pulmonary functional loss assessment and clinical stage classification of smoking-related COPD.
    AJR Am J Roentgenol, 190(2): W93-9. [Abstract] [Full-text]
82. A hybrid radiography/MRI system for combining hysterosalpingography and MRI in infertility patients: initial experience.
    AJR Am J Roentgenol, 190(2): W157-60. [Abstract] [Full-text]
83. Simple changes to 1.5-T MRI abdomen and pelvis protocols to optimize results at 3 T.
    AJR Am J Roentgenol, 190(2): W140-50. [Abstract] [Full-text]
84. The value of tandem CSF/MRI evaluation for predicting disseminated disease in childhood central nervous system neoplasms.
    J Neurooncol, 87(1): 97-102. [Abstract] [Full-text]
85. p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment.
    Arterioscler Thromb Vasc Biol, 28(2): 265-71. [Abstract] [Full-text]
86. The cerebellum in mild cognitive impairment and Alzheimer's disease - A structural MRI study.
    J Psychiatr Res. [Abstract] [Full-text]
87. Perfusion measurement using DCE-MRI: implications for hyperthermia.
    Int J Hyperthermia, 24(1): 91-6. [Abstract] [Full-text]
88. Assessment of the extension and the inflammatory activity in Crohn's disease: comparison of ultrasound and MRI.
    Abdom Imaging. [Abstract] [Full-text]
89. Functional MRI, DTI and neurophysiology in horizontal gaze palsy with progressive scoliosis.
    Neuroradiology. [Abstract] [Full-text]
90. Iliopsoas injury: an MRI study of patterns and prevalence correlated with clinical findings.
    Skeletal Radiol, 37(3): 245-9. [Abstract] [Full-text]
91. MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findings.
    J Neurol, 255(1): 1-10. [Abstract] [Full-text]
92. Ultrasound and MRI findings in appendicular and truncal fat necrosis.
    Skeletal Radiol, 37(3): 217-24. [Abstract] [Full-text]
93. Changes underlying the dynamic contrast-enhanced MRI response to treatment in rheumatoid arthritis.
    Skeletal Radiol, 37(3): 201-7. [Abstract] [Full-text]
94. Acute transverse myelitis with normal brain MRI : Long-term risk of MS.
    J Neurol, 255(1): 89-93. [Abstract] [Full-text]
95. Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer.
    Br J Cancer, 98(2): 289-93. [Abstract] [Full-text]
96. Mesoporous Silica Nanospheres as Highly Efficient MRI Contrast Agents.
    J Am Chem Soc. [Abstract] [Full-text]
97. Prolonged refractory status epilepticus with early and persistent restricted hippocampal signal MRI abnormality.
    J Neurol, 255(1): 112-6. [Abstract] [Full-text]
98. Categorization of non-mass-like breast lesions detected by MRI.
    Breast Cancer. [Abstract] [Full-text]
99. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis.
    Ann Rheum Dis. [Abstract] [Full-text]
100. MRI identifies otherwise occult disease in select patients with Paget disease of the nipple.
     J Am Coll Surg, 206(2): 316-21. [Abstract] [Full-text]
101. Narrow CSF space at high convexity and high midline areas in idiopathic normal pressure hydrocephalus detected by axial and coronal MRI.
     Neuroradiology, 50(2): 117-22. [Abstract] [Full-text]
102. Functional MRI of delayed chronic lithium treatment in rat focal cerebral ischemia.
     Stroke, 39(2): 439-47. [Abstract] [Full-text]
103. Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the multi-ethnic study of atherosclerosis (MESA).
     Stroke, 39(2): 329-35. [Abstract] [Full-text]
104. Clinical, laboratory, and MRI analysis of cellulite treatment with a unipolar radiofrequency device.
     Dermatol Surg, 34(2): 204-9; discussion 209. [Abstract] [Full-text]
105. MRI changes in the "normal" pineal gland following chemotherapy for suprasellar germ cell tumors.
     Pediatr Hematol Oncol, 25(1): 5-15. [Abstract] [Full-text]
106. MRI comparison of quantitative left ventricular structure, function and measurement reproducibility in patient cohorts with a range of clinically distinct cardiac conditions.
     Int J Cardiovasc Imaging. [Abstract] [Full-text]
107. Refining clinical phenotypes in septo-optic dysplasia based on MRI findings.
     Eur J Pediatr. [Abstract] [Full-text]
108. Congenital medulloblastoma with atypical MRI appearance.
     Pediatr Neurosurg, 44(2): 165-8. [Abstract] [Full-text]
109. MRI-guided interventions of the breast.
     J Magn Reson Imaging, 27(2): 347-55. [Abstract] [Full-text]
110. MRI-guided interventions of the musculoskeletal system.
     J Magn Reson Imaging, 27(2): 339-46. [Abstract] [Full-text]
111. Stem cell therapy: MRI guidance and monitoring.
     J Magn Reson Imaging, 27(2): 299-310. [Abstract] [Full-text]
112. Targeted drug delivery under MRI guidance.
     J Magn Reson Imaging, 27(2): 292-8. [Abstract] [Full-text]
113. Pulse sequences and system interfaces for interventional and real-time MRI.
     J Magn Reson Imaging, 27(2): 267-75. [Abstract] [Full-text]
114. MR systems for MRI-guided interventions.
     J Magn Reson Imaging, 27(2): 253-66. [Abstract] [Full-text]
115. MRI-guided cryotherapy.
     J Magn Reson Imaging, 27(2): 410-20. [Abstract] [Full-text]
116. Current status and future potential of MRI-guided focused ultrasound surgery.
     J Magn Reson Imaging, 27(2): 391-9. [Abstract] [Full-text]
117. In vivo imaging of transplanted hepatocytes with a 1.5-T clinical MRI system-initial experience in mice.
     Eur Radiol, 18(1): 59-69. [Abstract] [Full-text]
118. Measuring Brain Manganese and Iron Accumulation in Rats Following 14-weeks of Low-Dose Manganese Treatment Using Atomic Absorption Spectroscopy (AAS) and Magnetic Resonance Imaging (MRI).
     Toxicol Sci. [Abstract] [Full-text]
119. Anatomical evaluation of CT-MRI combined femoral model.
     Biomed Eng Online, 7(1): 6. [Abstract] [Full-text]

© 2005-2008 MRI Research Today. All Rights Reserved.